NCT00214968View on ClinicalTrials.gov

Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Narcolepsy
Interventions
DRUG

Modafinil

maximum dosage 400 mg/day (4 tablets)

Sponsors

Lead Sponsor

Cephalon
All Listed Sponsors
lead

Cephalon

INDUSTRY